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Is continuous transcutaneous monitoring
of PCO2 (TcPCO2) over 8 h reliable in adults?
J. P. JANSSENS, E. PERRIN, I. BENNANI, B. DE MURALT, V. TITELION and C. PICAUD
Pulmonary Rehabilitation Center, Hoˆpital de Rolle, Rolle, Vaud, Switzerland
Monitoring of non-invasive ventilation (NIV) in a non-intensive care unit (non-ICU) setting requires a method of
evaluating nocturnal PaCO2, such as transcutaneous CO2 monitoring (TcPCO2). However, changing the probe site
after 4 h and recalibrating (as recommended) is time-consuming and impractical. Continuous (8-h) TcPCO2
monitoring at a lower electrode temperature (438C) in this setting has never been formally studied.
Patients under intermittent NIV were studied (n=28, aged 69+9 years, PaO2: 71+13mmHg, PaCO2:
49+9mmHg). After calibration and stabilization of TcPCO2 (Radiometer
1 Tina TCM3 capnograph), arterial
blood gases (ABG) were measured and compared with transcutaneous readings. In 10 patients who underwent
continuous 8-h TcPCO2 recording, ABGs were also measured after 4 and 8 h.
The correlation between TcPCO2 and PaCO2 was highly significant (r
2=0?92, P50?0001). Mean (TcPCO2–
PaCO2) gradient (bias) was:72?8+3?8mmHg; limits of agreement were: (710?4; +4?8mmHg). TcPCO2–PaCO2
gradient was lowest (i.e. within-bias+2mmHg) between 40 and 54mmHg, increasing below and above these values.
Over 8 h, no significant drift of the TcPCO2 signal occurred (ANOVA). No discomfort or skin lesion was noted.
In conclusion, with an electrode temperature of 438C, 8-h continuous monitoring of TcPCO2 was well tolerated,
without any local side-effects or significant drift of TcPCO2 signal; when compared to previous reports, lowering
the electrode temperature did not decrease performance for CO2 monitoring.
Key words: blood gas monitoring; transcutaneous; carbon dioxide tension; intermittent positive pressure
ventilation.
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Non-invasive ventilation (NIV) aims to improve arterial
blood gases (ABGs) in patients with hypercapnic respira-
tory failure. Monitoring of NIV outside of an intensive care
unit (ICU) requires measuring ABGs by arterial puncture,
to ensure that NIV improves daytime hypoxia and
hypercapnia. However, daytime ABG measurements may
poorly reflect the quality of ventilation during sleep (1).
Pulse oximetry is valuable for adjusting FiO2, and may be
helpful in detecting desaturations related to air leaks,
ventilation–perfusion mismatch or hypoventilation,
although it may be of limited value in patients under
oxygen and NIV. Monitoring of arterial carbon dioxide
(CO2) is necessary to detect either nocturnal hyperventila-
tion or hypoventilation (1,2). Measuring transcutaneousReceived 27 September 2000 and accepted in revised form 19
January 2001.
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adults (1,2), but transcutaneous measurement of CO2
(TcPCO2) is well correlated with arterial measurements
(3). There are however a few reported drawbacks to the
method such as the necessity of changing the skin site of the
probe after 4 h and recalibrating, to avoid skin burning (a
time-consuming procedure) (3,4).
Although used in previous publications for overnight
studies (5–8), TcPCO2 monitoring has never been validated
for continuous 8-h monitoring. The present study aims to
show whether TcPCO2 recordings can be performed
continuously for 8 h, at a low electrode temperature of
438C, without recalibration, without any local side-effects,
without any significant alteration in the relationship
between TcPCO2 and PaCO2, or any significant drift of
the TcPCO2 signal.
Patients and methods
Patients treated by NIV for acute or chronic respiratory
failure at our institution were considered for the present
study. To be included, they had to be haemodynamically
stable (systolic blood pressure 4100mmHg and diastolic# 2001 HARCOURT PUBLISHERS LTD
332 J. P. JANSSENS ET AL.blood pressure 460mmHg), without any vasopressor
treatment, and willing to participate to the study protocol.
Transcutaneous measurements were performed using a
Radiometer Tina TCM3 capnograph (Radiometer1, Co-
penhagen, Denmark) with a combined TcPO2 (type Clark)/
TcPCO2 (type Stow-Severinghaus) electrode (model
E5280). The principle of the electrode has been previously
described (2). Calibration of the electrode was performed
before each new measurement, with a standard (5% CO2–
20?9% O2) calibration gas. The electrode was positioned on
the anterior chest wall, as suggested by the manufacturer,
after thoroughly cleansing the skin with alcohol. Care was
taken to avoid bony prominences, visible veins or any other
interference with skin perfusion. The temperature of the
electrode was set at 438C: this induces a local hyperaemia
which improves the permeability of the skin to gas
diffusion, and ‘arterializes’ the capillary blood to obtain
TcPCO2 readings closer to PaCO2 values, without inducing
local skin reactions or skin burns. This temperature is lower
than the recommended 44–458C. The manufacturer sug-
gests changing the site of the electrode every 4 h (and
recalibrating). However, patient tolerance to 5 h of con-
tinuous monitoring (i.e. without changing the position of
the probe) with the same electrode and capnograph, at
438C, has been reported (9). Arterial blood gases (ABGs)
were determined with a gas analyser (ABL 520; Radio-
meter1; Copenhagen, Denmark).
CORRELATIONS BETWEEN ARTERIAL
AND TRANSCUTANEOUS VALUES OF
PCO2 AND PO2 AT 438C
A 20-min period was required to allow for stabilization of
the signal before performing ABG measurements. After this
period, arterial blood samples for ABG determination were
obtained by puncture of the radial artery. Twenty-eight
patients were studied.
DRIFT OF TCPCO2 OVER AN 8-H
CONTINUOUS RECORDING
In 10 patients who accepted serial arterial punctures, arterial
blood samples were taken at the beginning of the TcPCO2
monitoring (after allowing for stabilization of signal), after
4 h and 8 h of continuous TcPCO2 monitoring (8 h is the
maximal recording capacity of the capnograph tested).
All arterial measurements were performed in steady state
situations (i.e. patients had been with or without non-
invasive ventilation for at least 30min, and transcutaneous
signals were stable), to take into account the lag time of the
capnograph (an estimation of the lag time, i.e. the time
occurring between a change in PaCO2 and it’s transcuta-
neous recording is 5+3min; range: 1–9min) (3).
STATISTICAL ANALYSIS
Comparisons between arterial and transcutaneous PO2 and
PCO2 values are expressed as described by Bland et al. (10):the mean difference between transcutaneous and arterial
values (TcPCO2–PaCO2) was calculated for PO2 and PCO2
(d: bias or accuracy), as well as the standard deviation of d
(s: precision) and the ‘limits of agreement’ between both
methods (d+2s; d72s).
Ninety-five per cent of the values of d are expected to be
within the limits of agreement. Transcutaneous and arterial
values were correlated by linear regression, with calculation
of Pearson’s coecient of correlation (r), and r2. Analysis
of variance for repeated measurements was used for other
comparisons (11).
StatView1 software for Windows, version 5?0?1. (SAS
Institute Inc, Cara, North Carolina, U.S.A.) was used for
statistical analysis.
This study protocol was approved by the Ethics
Committee of the University Hospital of Lausanne.
Results
PATIENTS
Twenty-eight patients (18 male, 10 female; age 69+9 years,
range, 46–85 years), treated by intermittent NIV, were
studied. Diagnoses included COPD (n=16), obesity–
hypoventilation syndrome (n=5), neuromuscular disorders
(n=2), sequelae of tuberculosis (n=2), severe kypho-
scoliosis (n=2) and pneumoconiosis (n=1). Mean body-
mass index (BMI) was 27? 3+6?1 kgm72 (range, 17–
40 kgm72). Pulmonary function tests were: FEV:
0?93+0?37 l (39?8+20% predicted); FVC1: 1?8+0?7 l
(60+25% predicted); FEV1/FVC: 54+17% (70+22%
predicted). Arterial blood gases were: PaO2:
70?8+12?9mmHg (range, 55–102mmHg); PaCO2:
49+8?6mmHg (range: 32–66mmHg).
COMPARISON BETWEEN
TRANSCUTANEOUS AND ARTERIAL
VALUES FOR PCO2
Correlation between TcPCO2 and PaCO2 values was highly
significant (r=0?96, P50?0001). The regression line
(TcPCO2=715?161?25PaCO2) was close to the identity
line (Fig. 1).The value of r2 was 0?92, i.e. 92% of the
variability of TcPCO2 was explained by changes in PaCO2.
The bias (or accuracy: d) was:72?8mmHg, i.e. on average,
TcPCO2 slightly underestimated PaCO2 values; precision
(s) was: 3?8mmHg; limits of agreement were: 710?4;
+4?8mmHg. There was a significant correlation between
TcPCO2–PaCO2 values and the mean of transcutaneous
and arterial CO2 values (r=0?691, 50?0001, regression
equation shown in Fig. 2). The best TcPCO2 readings (i.e.
TcPCO2–PaCO2 within d+2mmHg) were obtained be-
tween 40 and 54mmHg; below and above these values, the
TcPCO2–PaCO2 gradient increased (Fig. 2).
No significant correlation was found between the
TcPCO2–PaCO2 gradient and BMI, age, or any of the
functional parameters recorded (FEV1, FVC, FEV1/FVC).
FIG.1. Regression line for of TcPCO2 on PaCO2, and
identity line (- - - - -); values are in mmHg. Data shown
are those of 28 patients.
FIG.2. Values of TcPCO2–PaCO2 are plotted against
mean value of TcPCO2 and PaCO2, as described by Bland
and Altmann (10). Data shown (n=28 patients) are
expressed in mmHg. Also shown is the regression line
(with equation) for (TcPCO2–PaCO2) vs. mean value of
TcPCO2 and PaCO2. (d): bias of TcPCO2 compared with
PaCO2 (d+2s; d72s): limits of agreement.
FIG.3. Mean values of TcPCO2–PaCO2 and SD, in 10
patients in whom TcPCO2 was recorded continuously for
8 h; values at t=0, t=4h, and t=8h. The TcPCO2–
PaCO2 gradient did not change significantly over time
(ANOVA, P=0?08).
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TRANSCUTANEOUS AND ARTERIAL
VALUES FOR PO2
Correlation between arterial and transcutaneous values for
PO2 was also significant (r=0?636, P=0?0045), although
with a large variability around the regression line. Only
40% of the variability of PtcO2 was explained by changes
in PaO2 (r
2=0?40). Bias (d: accuracy) was: 710?9mmHg;
precision (s) was: 10mmHg, i.e. TcPO2 underestimated
PaO2 by 10?9+10mmHg; limits of agreement were:
730?9mmHg; +9?2mmHg. There was no significant
correlation between TcPO2–PaO2 and the mean oftranscutaneous and arterial O2 values. As with TcPCO2,
there was no significant correlation between the TcPO2–
PaO2 gradient and BMI, age, or any of the functional
parameters recorded (FEV1, FVC, FEV1/FVC).
DRIFT OF TcPCO2 SIGNAL OVER 8 H
For the 10 patients tested over 8 h, the mean values for
TcPCO2–PaCO2 were, at t=0: 5?7+3?8mmHg; at t=4h:
2?1+3?9mmHg and at t=8h: 2?0+5?2 mmHg. Mean
TcPCO2–PaCO2 actually decreased over the 8-h observa-
tion period; these changes over time were however not
significant (ANOVA for repeated measurements, P=0?08;
Fig. 3). No local discomfort, burn or blister occurred after
8 h.
Discussion
The present study shows that TcPCO2 can be measured
continuously for 8 h in adults at a probe temperature of
438C without recalibration or changing skin probe position,
while maintaining a highly significant correlation between
PaCO2 and TcPCO2, without any discomfort for the
patient, and with no significant drift or deterioration in
the TcPCO2 signal.
PERFORMANCE OF THE CAPNOGRAPH
AT DIFFERENT ELECTRODE
TEMPERATURES
The lowest reported electrode temperature used for
monitoring TcPCO2 with a Radiometer TCM-3 capno-
graph is, to our knowledge, 428C; however, correlation with
PaCO2 was not reported (12). Albeit for the study by
Rosner et al. (9), previously published values of correlations
between TcPCO2 and PaCO2 with the Radiometer
1 TCM-
3 capnograph used probe temperatures of 44 or 458C (4,
334 J. P. JANSSENS ET AL.13–17) (Table 1). Despite a lower probe temperature,
correlation coecients obtained in the present study are
higher than previously published data (4, 13–15); precision
and limits of agreement in the present study are similar to
published values obtained at 448C with the same capno-
graph (15). Although Sridhar et al. showed that increasing
probe temperature to 458C significantly increases the
accuracy and precision of TcPO2 and TcPCO2 measure-
ments, this probe temperature cannot be used for several
hours (16) (Table 1).
The reason for the higher bias and wider limits of
agreement in the study by Rosner et al. is unclear;
particular attention was taken in the present study to
recalibrate the capnograph before each new patient, to
thoroughly cleanse the skin with alcohol, and to allow for
stabilization of the TcPCO2 signal: indeed, time for
TcPCO2 signal to stabilize increases at lower electrode
temperature. In summary, the present data suggest that
using a temperature of 438C is not associated with a
decreased electrode performance for TcPCO2 measure-
ments, although decreasing probe temperature is associated
with a prolonged response time (16). Interestingly, optimal
performance (i.e. TcPCO2–PaCO2 gradient within
bias+2mmHg) of the capnograph was in the 40–54mmHg
range (i.e. in a normal to moderate hypercapnia range: Fig.
2), which is what one would require for monitoring and
adjusting NIV; the TcPCO2–PaCO2 gradient increased for
extreme values: lower values of TcPCO2 underestimated
PaCO2 whilst higher TcPCO2 values overestimated PaCO2.
CLINICAL VALUE OF TcPO2
As previously described (17), and with the exception of the
study by Sringhar et al. (16), TcPO2 values, although
significantly correlated with PaO2, were unreliable for
clinical use, with a large dispersion of values around the
regression line. Decreasing the electrode temperature
further decreases the precision of the TcPO2 signal.TABLE 1. Correlations between TcCO2 and PaCO2, bias and lim
using the Radiometer TINA TCM-3 capnograph at different el
First author
(with reference no.)
No. of
patients
Temperature
of probe*
r
Hoffmann (13) 9 45 0?84
Sridhar (16) 24 45 NA
Drummond (4) 64 44 0?88
Kesten (14) 20 44 0?90
Palmisano (15) 251 44 0?93
Lang (17) 54 44 NA
Rosner (9) 10 43 NA
Present study 28 43 0?96
NA: not available from original publication.
d: bias; s: SD of bias; limits of agreement: d72s; d+2s, as expr
*Temperature in 8C.Although widely used in neonatal and infant monitoring,
in an adult population, pulse oximetry is far more reliable
than TcPO2 monitoring (1,2). In fact, in adults, the strong
influence of cutaneous blood flow on TcPO2 has led to the
use of TcPO2 monitoring as a measure of local perfusion
rather than an estimate of arterial PaO2 (2).
DRIFT OF TcPCO2 SIGNAL OVER TIME AND
TOLERANCE TO PROLONGED
CONTINUOUS MEASURING
There are few reports measuring the drift of the TcPCO2
signal in a clinical setting (3,5,9,18,19). Reported TcPCO2
signal drift ranges from non-significant to 1mmHgh71.
Tolerance to continuous TcPCO2 measurement has been
previously reported for up to 5 h at 438C, using a
Radiometer Tina TCM3 Capnograph (9), and up to 6 h,
using a Kontron capnograph, without any local side-effects
(5). Mahutte et al. (18) recorded TcPCO2 for 8 h at 43?58C
in 47 adult patients: mild erythema was frequent, resolving
after 24–48 h; blisters developed in three patients (in whom
the sensor had been left inadvertantly in place for more
than 8 h). A temperature of 438C therefore appears to be
the highest recommendable electrode temperature for a safe
6–8 h monitoring.
Despite the results presented, some important caveats
must be kept in mind when using transcutaneous CO2
monitoring: there is a clear possibility of impredictable
errant values; occasional unexplained fluctuations in
TcPCO2 occur without any clear technical explanation
(although this was not the case in the patients studied, it is
an occasional occurrence in current clinical practice) one
must also bear in mind the lag time of transcutaneous
measurements (average 5+3min) which precludes the
recording of brief ventilatory events such as obstructive
apneas (3); regular recalibration and changing of probe
membrane are mandatory for optimal transcutaneousits of agreement in previous publications and present study
ectrode temperatures
d s Limits of agreement
(mmHg) (mmHg) d72s d+2s
NA NA NA NA
0?2 1 71?7 2?2
NA NA NA NA
NA NA NA NA
1?3 3?9 76?5 9?1
70?3 8?5 717?2 16?8
8?1 7?8 77?5 23?7
72?8 3?8 710?4 4?8
essed by Bland and Altman (see ref. 10).
IS CONTINUOUS (TCPACO2) OVER 8 H RELIABLE IN ADULTS? 335signals; also, transcutaneous measurements are adversely
affected by cutaneous vasoconstriction due to hypovolae-
mic or cardiogenic hypotension, vasoconstricting agents,
and hypothermia which all markedly increase the TcPCO2–
PaCO2 gradient (2). Noteworthy is the fact that none of the
patients studied in this report were haemodynamically
unstable or receiving vasopressor treatment.
In summary, our results show that continuous monitor-
ing of TcPCO2 for up to 8 h, at a probe temperature of
438C, is well tolerated in patients during NIV, and is not
associated with a significant drift of the TcPCO2 signal, or a
decrease in electrode performance. The range of optimal
performance of the electrode (40–54mmHg) is quite
suitable for adjusting and monitoring NIV. However, these
results apply only for adults and for the monitor tested.
Taking into account the above-mentioned caveats and
limitations, TcPCO2 is a reliable method of continuous
monitoring of NIV, of estimating the average impact of
NIV on nocturnal PaCO2, and documenting periods of
hypoventilation lasting more than a few minutes.
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